Scott Segal

Scott Segal is a declared insider of Protea Biosciences Group, Inc., with filings sourced from SEC (Form 4). Between 27 December 2011 and 24 March 2017, the trades on record add up to 6 filings.

Purchases make up the whole of the open-market record (2 purchases, €223k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant.

The newest entry dates from 4 April 2017: a transaction, in Protea Biosciences Group, Inc. The clock since the last published purchase (13 February 2014) now reads 4,635 days. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.